X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (443) 443
index medicus (371) 371
transplantation (266) 266
immunology (232) 232
male (212) 212
female (200) 200
highly sensitized patients (175) 175
surgery (157) 157
hla antigens - immunology (154) 154
animals (150) 150
kidney transplantation (133) 133
adult (132) 132
middle aged (128) 128
graft rejection - immunology (117) 117
sensitized patients (108) 108
antibodies (99) 99
kidney-transplantation (93) 93
histocompatibility testing (91) 91
kidney transplantation - immunology (89) 89
desensitization (79) 79
renal-transplantation (78) 78
antibody-mediated rejection (75) 75
recipients (71) 71
hla antibodies (69) 69
treatment outcome (69) 69
graft rejection - prevention & control (67) 67
tissue donors (65) 65
donor-specific antibodies (63) 63
allergy (61) 61
histocompatibility antigens (61) 61
hla histocompatibility antigens (61) 61
viral antibodies (61) 61
kidneys (60) 60
hla (56) 56
asthma (55) 55
mice (55) 55
isoantibodies - immunology (54) 54
analysis (53) 53
aged (50) 50
isoantibodies - blood (50) 50
rejection (49) 49
adolescent (47) 47
urology & nephrology (46) 46
plasmapheresis (45) 45
cross-match (44) 44
graft survival (44) 44
histocompatibility testing - methods (44) 44
risk factors (44) 44
antigens (43) 43
time factors (43) 43
flow cytometry (42) 42
graft survival - immunology (41) 41
positive cross-match (41) 41
sensitized mice (41) 41
histocompatibility (40) 40
inflammation (40) 40
rituximab (40) 40
child (39) 39
disease models, animal (38) 38
respiratory system (38) 38
transplantation of organs, tissues, etc (38) 38
intravenous immunoglobulin (37) 37
pharmacology & pharmacy (37) 37
graft rejection (36) 36
health aspects (36) 36
survival (36) 36
algorithms (35) 35
allergy and immunology (35) 35
clinical-relevance (34) 34
immunotherapy (34) 34
desensitization, immunologic - methods (33) 33
mediated rejection (32) 32
mice, inbred balb c (32) 32
retrospective studies (32) 32
waiting lists (32) 32
alloantibody (31) 31
highly sensitized (31) 31
immunization (31) 31
immunoglobulins (31) 31
immunosuppressive agents - therapeutic use (31) 31
kidney transplantation - methods (31) 31
sensitized guinea-pigs (31) 31
kidney transplantation - adverse effects (30) 30
rats (30) 30
antibodies - immunology (29) 29
transplants & implants (29) 29
intravenous immune globulin (28) 28
medicine, general & internal (28) 28
research (28) 28
antibodies - blood (27) 27
biochemistry & molecular biology (27) 27
expression (27) 27
flow-cytometry (27) 27
immunosuppression (27) 27
antibody specificity (26) 26
hla-specific antibodies (26) 26
living donors (26) 26
molecularly based algorithm (26) 26
renal transplantation (26) 26
transplantation, homologous (26) 26
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (690) 690
Japanese (8) 8
Spanish (7) 7
French (5) 5
German (2) 2
Hungarian (1) 1
Korean (1) 1
Polish (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Transplantation, ISSN 0041-1337, 04/2017, Volume 101, Issue 4, pp. e86 - e92
Journal Article
Human Immunology, ISSN 0198-8859, 07/2019, Volume 80, Issue 7, pp. 478 - 486
Accurate identification of HLA antibodies using the single antigen bead (SAB) assay is critical for assessment of pre/post-transplant immunological risk and... 
Prozone effect | Highly sensitized patients | Transplantation | Single antigen bead assay | HLA antibodies | IMPACT | ASSAYS | INTERFERENCE | IMMUNOLOGY | TITER | Viral antibodies | Ethylenediaminetetraacetic acid | Antibodies | Histocompatibility antigens | Digital television | HLA histocompatibility antigens
Journal Article
Transplantation, ISSN 0041-1337, 05/2010, Volume 89, Issue 9, pp. 1095 - 1102
Background. We have shown that high-dose intravenous immune globulin (IVIG; 2 g/kg x 2 doses) + rituximab (1 g x 2 doses) was effective in lowering anti-human... 
Acute antibody-mediated rejection | Daclizumab | Acute cell- mediated rejection | Kidney transplant | Rituximab | IVIG | Alemtuzumab | Antithymocyte globulin | Highly sensitized | RHEUMATOID-ARTHRITIS | SURGERY | IMMUNOGLOBULIN | GAMMA-GLOBULIN | IMMUNOLOGY | TRANSPLANTATION | RESISTANT REJECTION | ACUTE HUMORAL REJECTION | INDUCTION THERAPY | ANTIBODY-MEDIATED REJECTION | AUTOIMMUNE-DISEASES | ALLOGRAFT RECIPIENTS | Acute cell-mediated rejection | STAGE RENAL-DISEASE | Humans | Middle Aged | Ganciclovir - analogs & derivatives | Antibodies, Monoclonal - therapeutic use | Male | Flow Cytometry | Virus Diseases - drug therapy | Autoantibodies - drug effects | Aged, 80 and over | Ganciclovir - therapeutic use | Adult | Female | Drug Therapy, Combination | Kidney Failure, Chronic - immunology | Antibodies, Monoclonal, Murine-Derived | Kidney Failure, Chronic - surgery | Antiviral Agents - therapeutic use | Histocompatibility Testing | Graft Rejection - prevention & control | HLA Antigens - immunology | Graft Survival | Survival Rate | Autoantibodies - immunology | Immunoglobulins, Intravenous - therapeutic use | Adolescent | Kidney Transplantation - mortality | T-Lymphocytes - immunology | Aged | Kidney Transplantation - immunology | Virus Diseases - prevention & control | Desensitization, Immunologic - methods | Immunologic Factors - therapeutic use
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 03/2011, Volume 11, Issue 3, pp. 470 - 477
Journal Article
Journal Article
Journal Article